News
FAPESP and GSK announce result of call for proposals Versão em português
Three research projects were selected and will be funded up to 24 months (GSK)
FAPESP and GlaxoSmithKline (GSK) make public the result of a call for proposals opened in July, 2013 in the following topics: Metabolic Diseases; Tropical and Neglected Diseases; Infectious Diseases; Respiratory Diseases; Inflammation and Immunology; Biopharmaceuticals and Vaccines.
The total amount available for this call for proposals is US$ 600.000, with a maximum of US$ 200.000 per project.
The duration of selected projects will be of up to 24 months.
Selected proposals:
| Researchers | Project title |
| Paula Rahal Instituto de Biociências, Letras e Ciências Exatas (IBILCE), UNESP |
Therapeutic potential of Flavonoid-like Drugs on Hepatitis C Virus Infection |
| Arlene Gonçalves Correa Centro de Ciências Exatas e de Tecnologia (CCET), UFSCAR |
Quinoxaline derivatives as antiparasitic drugs:proof of concept |
| Flavio da Silva Emery Faculdade de Ciências Farmacêuticas de Ribeirão Preto (FCFRP), USP |
Exploring epigenetic targets to fight neglected diseases: Selective sirtuin-2 inhibitors as leishmanicidal compounds |
The call for proposals is available at: www.fapesp.br/en/7858.